Mitsubishi UFJ Capital — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
DiscGenics develops an allogeneic, injectable disc progenitor cell therapy (IDCT/rebonuputemcel) for painful lumbar degenerative disc disease, currently advancing toward a Phase III clinical program.
BiotechHealthtechMedical DevicesSalt Lake City, US
Flagg Flanagan(CEO & Chairman)inBob Wynalek(COO & Board Member)in
Co-investorsMedical Incubator Japan K.K.
Subsclife operates a subscription-based rental service for furniture and home appliances, offering designer furniture brands, lighting, and appliances such as chairs, tables, refrigerators, and washing machines.
ConsumerE-commerceMarketplaces
Co-investorsKDDI Open Innovation FundCyberAgent CapitalSMBC Venture CapitalUNITEDXTech Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.